2B4/CD48-mediated regulation of lymphocyte activation and function

Journal of Immunology

Volumn 175, Issue 4, 2005, Pages 2045-2049

  Assarsson, Erika ^a,b   Kambayashi, Taku ^c   Persson, Catrine M ^a   Chambers, Benedict J ^a   Ljunggren, Hans Gustaf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD48 ANTIGEN; IMMUNOGLOBULIN; LIGAND; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2B4; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL STIMULATION; HEMATOPOIETIC CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

EID: 23444453820     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.4.2045     Document Type: Short Survey

References (58)

1. Coyle, A. J., and J. C. Gutierrez-Ramos. 2001. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2: 203-209.
2. Carreno, B. M., and M. Collins. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20: 29-53.
3. Quezada, S. A., L. Z. Jarvinen, E. F. Lind, and R. ]. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22: 307-328.
4. Sidorenko, S. P., and E. A. Clark. 2003. The dual-function CD150 receptor subfamily: the viral attraction. Nat. Immunol. 4: 19-24.
5. Fraser, C. C., D. Howie, M. Morra, Y. Qiu, C. Murphy, Q. Shen, J. C. Gutierrez-Ramos, A. Coyle, G. A. Kingsbury, and C. Terhorst. 2002. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family. Immunogenetics 53: 843-850.
6. Boles, K. S., S. E. Stepp, M. Bennett, V. Kumar, and P. A. Mathew. 2001. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol. Rev. 181: 234-249.
7. Tangye, S. G., J. H. Phillips, and L. L. Lanier. 2000. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin. Immunol. 12: 149-157.
8. Veillette, A., and S. Latour. 2003. The SLAM family of immune-cell receptors. Curr. Opin. Immunol. 15: 277-285.
9. KUbota, K. 2002. A structurally variant form of the 2B4 antigen is expressed on the cell surface of mouse mast cells. Microbiol. Immunol. 46: 589-592.
10. + T cell proliferation by 2B4/CD48 interactions. J Immunol. 167: 6706-6710.
11. Valiante, N. M., and G. Trinchieri. 1993. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178: 1397-1406.
12. Nakajima, H., M. Cella, H. Langen, A. Friedlein, and M. Colonna. 1999. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 29: 1676-1683.
13. Boles, K. S., H. Nakajima, M. Colonna, S. S. Chuang, S. E. Stepp, M. Bennett, V. Kumar, and P. A. Mathew. 1999. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. Tissue Antigens 54: 27-34.
14. Romero, X., D. Benitez, S. March, R. Vilella, M. Miralpeix, and P. Engel. 2004. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4). Tissue Antigens 64: 132-144.
15. Munitz, A., I. Bachelet, S. Fraenkel, G. Karz, O. Mandelboim, H. U. Simon, L. Moretta, M. Colonna, and F. Levi-Schaffer. 2005. 2B4 (CD244) is expressed and functional on human eosinophils. J. Immunol. 174: 110-118.
16. + T cells in HIV-1-infected patients with progressing disease. J. Immunol. 162: 7563-7568.
17. +, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection Blood 103: 2238-2247.
18. Latchman, Y., P. F. McKay, and H. Reiser. 1998. Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol 161: 5809-5812.
19. Brown, M. H., K. Boles, P. A. van der Merwe, V. Kumar, P. A. Mathew, and A. N. Barclay. 1998. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. exp. Med. 188: 2083-2090.
20. Kato, K., M. Koyanagi, H. Okada, T. Takanashi, Y. W. Wong, A. F. Williams, K. Okuihura, and H. Yagita. 1992. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J. Exp. Med. 176: 124l-1249.
21. Reiser, H. 1990. sgp-60, a signal-transducing glycoprbtein concerned with T cell activation through the T cell receptor/CD3 complex. J. Immunol. 145: 2077-2086.
22. Thorley-Lawson, D. A., R. T. Schooley, A. K. Bhan, and L. M. Nadler. 1982. Epstein-Barr virus superinduces a new human B cell differentiation antigen (B-LAST 1) expressed on transformed lymphoblasts. Cell 30: 415-425.
23. Yokoyama, S., D. Staunton, R. Fisher, M. Amiot, J. J. Fortin, and D. A. Thorley-Lawson. 1991. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. J. Immunol. 146: 2192-2200.
24. Assarsson, E., T. Kambayashi, J. D. Schatzle, S. O. Cramer, A. von Bonin, P. E. Jensen, H. G. Ljunggren, and B. J. Chambers. 2004. NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J. Immunol. 173: 174-180.
25. Stepp, S. E., J. D. Schatzte, M. Bennett, V. Kumar, and P. A. Mathew. 1999. Gene structure of the murine NK cell receptor 2B4: presence of two alternatively spliced isoforms with distinct cytoplasmic domains. Eur. J. Immunol. 29: 2392-2399.
26. Schatzle, J. D., S. Sheu, S. E. Stepp, P. A. Mathew, M. Bennett, and V. Kumar. 1999. Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4. Proc. Natl. Acad. Sci. USA 96: 3870-3875.
27. Vaidya, S. V., S. E. Stepp, M. E. McNerney, J. K. Lee, M. Bennett, K. M. Lee, C. L. Stewart, V. Kumar, and P. A. Mathew. 2005. Targeted disruption of the 2B4 gene in mice reveals an in vivo roleof 2B4 (CD244) in the rejection of B16 melanoma cells. J. Immunol. 174: 800-8007.
28. Lee, K. M., M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar. 2004. 2B4 acts as a non-major histocompatibiliry complex binding inhibitory receptor on mouse natural killer cells. J. Exp. Med. 199: 1245-1254.
29. Mooney, J. M., J. Klem, C. Wulfing, L. A. Mijares, P. L. Schwartzberg, M. Bennett, and J. D. Schatzle. 2004. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression. J. Immunol. 173: 3953-3961.
30. McNerney, M. E., D. Guzior, and V. Kumar. 2005. 2B4 (CD244)-CD48 interactions provide a novel MHC class I-independent system for NK cell self-tolerance in mice. Blood in press.
31. Kubin, M. Z., D. L. Parshley, W. Din, J. Y. Waugh, T. Davis-Smith, C. A. Smith, B. M. Macduff, R. J. Armitage, W. Chin, L. Cassiano, et al. 1999. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48. Eur. J. Immunol. 29: 3466-3477.
32. Kumaresan, P. R., and P. A. Mathew. 2000. Structure of the human natural killer cell receptor 2B4 gene and identification of a novel alternative transcript. Immunogenetics 51: 987-992.
33. Sivori, S., S. Parolini, M. Falco, E. Marcenaro, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2000. 2B4 functions as a coreceptor in human NK cell activation. Eur. J. Immunol. 30: 787-793.
34. Sivori, S., M. Falco, E. Marcenaro, S. Parolini, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2002. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl. Acad. Sci. USA 99: 4526-4531.
35. Chen, R., F. Relouzat, R. Roncagalli, A. Aoukary, R. Tan, S. Latour, and A. Veillette. 2004. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol. Cell. Biol. 24: 5144-5156.
36. Eissmann, P., L. Beauchamp, J. Wooters, J. C. Tilton, E. O. Long, and C. Watzl. 2005. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105: 4722-4729.
37. Engel, P., M. J. Eck, and C. Terhorst. 2003. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat. Rev. Immunol. 3: 813-821.
38. Tangye, S. G., J. H. Phillips, L. L. Lanier, and K. E. Nichols. 2000. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165: 2932-2936.
39. Nakajima, H., M. Cella, A. Bouchon, H. L. Grierson, J. Lewis, C. S. Ducken, J. I. Cohen, and M. Colonna. 2000. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30: 3309-3318.
40. Benoit, L., X. Wang, H. F. Pabst, J. Dutz, and R. Tan. 2000. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165: 3549-3553.
41. Parolini, S., C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. D. Ochs, H. Wolf, J. Y. Bonnefoy, R. Biassoni, et al. 2000. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192: 337-346.
42. Watzl, C., and E. O. Long. 2003. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med. 197: 77-85.
43. Sayos, J., K. B. Nguyen, C. Wu, S. E. Stepp, D. Howie, J. D. Schatzle, V. Kumar, C. A. Biron, and C. Terhorst. 2000. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int. Immunol. 12: 1749-1757.
44. Morra, M., J. Lu, F. Poy, M. Martin, J. Sayos, S. Calpe, C. Gullo, D. Howie, S. Rietdijk, A. Thompson, et al. 2001. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J. 20: 5840-5852.
45. Klem, J., P. C. Verrett, V. Kumar, and J. D. Schatzle. 2002. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J. Immunol. 169: 55-62.
46. Azuma, M., H. Yssel, J. H. Phillips, H. Spits, and L. L. Lanier. 1993. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177: 845-850.
47. Bourgeois, C., B. Rocha, and C. Tanchot. 2002. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297: 2060-2063.
48. Lee, K. M., S. Bhawan, T. Majima, H. Wei, M. I. Nishimura, H. Yagita, and V. Kumar. 2003. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells. J. Immunol. 170: 4881-4885.
49. Klyushnenkova, E. N., L. Li, R. J. Armitage, and Y. S. Choi. 1996: CD48 delivers an accessory signal for CD40-mediated activation of human B cells. Cell Immunol. 174: 90-98.
50. Loertscher, R., and P. Lavery. 2002. The role of glycosyl phosphatidyl inositol (GPI)-anchored cell surface proteins in T-cell activation. Transplant. Immunol. 9: 93-96.
51. Garnett, D., A. N. Barclay, A. M. Carmo, and A.D. Beyers. 1993. The association of the protein tyrosine kinases p56lck and p60fyn with the glycosyl phosphatidylinositol-anchored proteins Thy-1 and CD48 in rat thymocytes is dependent on the state of cellular activation. Eur. J. Immunol. 23: 2540-2544.
52. Stefanova, I., V. Horejsi, I. J. Ansotegui, W. Knapp, and H. Stockinger. 1991. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254: 1016-1019.
53. Fukushima, K., Y. Ikehara, and K. Yamashita. 2005. Functional role played by the glycosylphosphatidylinositol anchor glycan of CD48 in interleukin-18-induced interferon-γ production. J. Biol. Chem. 280: 18056-18062.
54. Lee, K. M., J. P. Forman, M. E. McNetney, S. Stepp, S. Kuppireddi, D. Guziot, Y. E. Latchman, M. H. Sayegh, H. Yagita, C. K. Park, et al. 2005. Requirement of homotypic NK cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood in press.
55. Assarsson, E., T. Kambayashi, C. M. Persson, H. G. Ljunggren, and B. J. Chambers. 2005. 2B4 co-stimulation: NK cells and their control of adaptive immune responses. Mol. Immunol. 42: 419-423.
56. Raulet, D. H. 2004. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5: 996-1002.
57. Flodström, M., F. D. Shi, N. Sarvetnick, and H. G. Ljunggren. 2002. The natural killer cell-friend or foe in autoimmune disease? Scand. J. Immunol. 55: 432-441.
58. Kos, F. J., and E. G. Engleman. 1996. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell. Immunol. 173: 1-6.